Prostate Cancer Risk Test – identify your genetic risk early
Prostate cancer can affect any man—even without a family history. With the AntePC Prostate Cancer Risk Test, you’ll learn your personal genetic risk for prostate cancer. The scientifically validated test analyzes your genetic profile and helps you take targeted preventive action early—simply, safely, and conveniently from home.
Your benefits at a glance
- Genetic risk test via cheek swab – easily done at home
- Calculation of your polygenic prostate cancer risk
- Personalized recommendations on when and how often preventive screenings are advisable
- Concrete measures for risk reduction
- CE-certified, GDPR-compliant, and clinically validated
- Optional: Video consultation for personal results discussion (one-time fee of €150).
Who is the Prostate Cancer Risk Test for?
- Recommended for all men over 40 years old
- Ideal for health-conscious men—with or without a family history of cancer
- Available everywhere thanks to at-home testing and digital prevention recommendations

What does the prostate cancer risk test analyze?
The test calculates your risk using a polygenic risk score (PRS) that combines the effects of 121 common genetic variants. Unlike rare single-gene mutations (e.g., BRCA1/BRCA2), polygenic risk is based on the interaction of many variants—so your risk can be elevated even without a family history.
The analysis also takes into account your age, ancestry, and sex to create a personalized prevention plan with clinical recommendations.
Result: Genetic counseling will be provided verbally. Alternatively, written counseling is possible if you give explicit consent. Your consent or refusal will be documented.
What does the result mean for you?
- Your personal risk score compared to the general male population
- Assessment of your likelihood of developing prostate cancer within the next 10 years
- Individual medical recommendations for prevention and early detection
- A medical report for you and your treating physician
Important notes
- This test is not a diagnostic procedure.
- A high risk does not automatically mean illness – a low risk does not rule it out
- Rare high-risk mutations (e.g., BRCA1, BRCA2) are not detected
- Based on data from the UK Biobank – CE-certified as an IVD in the EU and the United Kingdom
- Scientific models can evolve with new research findings
Legal & scientific information
In accordance with the German Genetic Diagnostics Act (GenDG), you will receive all legally required information in writing before and after the test.
-
Before the test: Written information about the purpose, procedure, and possible outcomes
-
After the test: Digital report and personalized prevention plan
-
Optional: Personalized counseling via video consultation (€150) – book here
Conclusion: Know early. Prevent better.
With the AntePC Prostate Cancer Risk Test, you’ll understand your genetic risk—and can take early action to protect your long-term health.
👉 Know your risk now – order the Prostate Cancer Risk Test easily online.